ITRI

Personal Genomics says its platform will be able to sequence a human genome for less than $1,000.

IP Roundup

Premium

Fluidigm, Expression Analytics, Maven Technologies, Van Andel Research Institute, Industrial Technology Research Institute, Northwestern University, Bio-Rad Laboratories, Illumina, Aperio Technologies, Samsung Electronics

IP Roundup

Premium

Columbia University, Riken, Industrial Technology Research Institute, Life Technologies, Syngenta, Petr Nikitin, Johns Hopkins University

The ITRI-funded group, about 30 people strong and called "Cracker," is currently looking for investors and strategic partners in order to spin out into a company and speed up the development of its technology. Eventually, the chip might allow users to sequence millions of single DNA strands in parallel in real time.

The team's patent-pending method uses arrays of up to a million nanowells on a composite "sTOP" chip — short for "sequencing on top of a photodiode" — that consists of three layers: a light-emitting tier in which the nanowells are embedded, a filtering tier, and a photo-sensing tier.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.